Leidos (LDOS) investor relations material

Strategic direction and growth pillars

• NorthStar 2030 strategy focuses on five growth pillars: defense tech, energy infrastructure, cyber, mission and digital, and managed health services, with recent investments in energy and cyber capabilities.

• Organic growth is accelerating, with 4% in Q2, 5% in the first half, and guidance raised to 8% for the second half, driven by defense tech, energy, and FAA modernization programs.

• FAA modernization, including the Common Automation Platform, is a multi-billion dollar opportunity, expected to drive development and sustainment revenues over several years.

• The IFPC program is scaling production, expected to double output by year-end, with significant growth anticipated in 2027.

• ENTRUST acquisition doubled the energy business, expanded the addressable market by 3x, and is integrating technology for efficiency and new opportunities.

Segment performance and key programs

• Health segment remains highly profitable, with the VBA medical disability exam program generating over $1 billion in revenue and strong margins, though incentive payments are paused until year-end.

• VBA contract recompete may consolidate providers, with Leidos well-positioned due to coverage across all regions and sustained high exam volumes post-PACT Act.

• MHS GENESIS program continues with a one-year extension; future scope may shift software licensing directly to vendors, but Leidos expects ongoing support and modernization roles.

• Defense segment grew 6% in the quarter, with a 2.2x book-to-bill ratio, driven by IFPC, ABAD, and new awards in space and maritime unmanned surface vessels.

• Homeland segment grew 32% (15% organic), supported by FAA, TSA, and international contracts, with margin improvement and further upside expected.

Financial outlook and capital allocation

• Margins in health are moderating to about 20% in the second half due to incentive suspension, impacting overall company margins, but defense and homeland are expected to drive future margin growth.

• CapEx for the year was revised down to $250 million, focusing on facility modernization and production capacity, with strong cash flow conversion expected.

• Integration of ENTRUST is on track, with back office and leadership alignment expected by year-end, and technology adoption driving efficiency.

• Portfolio strength allows for raised guidance despite health headwinds, with defense tech and energy businesses highlighted as underappreciated growth drivers.